Chronic Sinusitis Clinical Trial at Advanced ENT & Allergy

If you are living with chronic sinusitis and considering sinus surgery, you may be interested in a clinical research study at Advanced ENT & Allergy. The RESTORE-2 RCT is evaluating an investigational paclitaxel-coated sinus balloon used as an adjunct to endoscopic sinus surgery in adults with chronic rhinosinusitis.

This clinical trial is being led by Steven Shotts, M.D., at Advanced ENT & Allergy.

 What Is Chronic Rhinosinusitis? 

Chronic rhinosinusitis, commonly called chronic sinusitis, is a condition that causes inflammation and swelling of the sinuses that lasts for 12 weeks or longer. Symptoms may include:

• Nasal congestion or stuffiness
• Facial pressure or pain
• Difficulty breathing through the nose
• Reduced sense of smell
• Nasal drainage
• Frequent or persistent sinus symptoms

For some patients, medications and other treatments may not provide enough relief. In these cases, an ENT specialist may recommend endoscopic sinus surgery.

About the RESTORE-2 Sinus Clinical Trial The RESTORE-2 RCT is a clinical study evaluating the safety and efficacy of a paclitaxel-coated sinus balloon when used as an adjunct to endoscopic sinus surgery in adults with chronic rhinosinusitis.

The investigational sinus balloon is designed to deliver paclitaxel to the sinus area during the surgical procedure. The study will help researchers evaluate whether this approach may provide a safe and effective treatment option for adults with chronic sinusitis.

Why Consider Participating in a Sinus Clinical Trial?

Participating in a clinical trial can give eligible patients the opportunity to contribute to research evaluating potential new treatment options for chronic sinusitis.

By participating, you may:

• Learn more about an investigational treatment for chronic rhinosinusitis
• Receive care from an experienced ENT clinical research team
• Help advance research into new approaches to sinus surgery and chronic sinusitis treatment
• Contribute to research that may help improve treatment options for future patients
  

Who May Qualify for the Chronic Sinusitis Study?

This clinical trial is for adults with chronic rhinosinusitis who are candidates for endoscopic sinus surgery. Additional eligibility requirements apply.

Our study team will review your medical history and sinus condition to determine whether you may qualify for the RESTORE-2 clinical trial.

How to Learn More About the Clinical Trial

If you have chronic sinusitis and are considering sinus surgery, contact Advanced ENT & Allergy to learn more about the RESTORE-2 clinical trial and whether you may qualify.

Primary Investigator:
Steven Shotts, M.D.

Advanced ENT & Allergy
Rhonda Dase, Study Coordinator
(502) 399-1885 x 80071
rdase@advancedentandallergy.com

Explore Your Options for Chronic Sinusitis Treatment

If chronic sinusitis continues to affect your daily life, you may have treatment options. The RESTORE-2 clinical trial is evaluating a new investigational approach to treatment during endoscopic sinus surgery.

Contact Advanced ENT & Allergy today to learn more about the study and see if you may qualify.